Congestive Heart Failure Treatment Device Market Size

The congestive heart failure treatment device market is in a period of fluid transformation. Senior decision-makers must navigate rapidly advancing device technologies, evolving clinical requirements, and new procurement strategies—all of which are redefining investment priorities in the sector.

Market Snapshot: Congestive Heart Failure Treatment Device Market

The Congestive Heart Failure Treatment Device Market expanded from USD 14.56 billion in 2025 to USD 15.64 billion in 2026 and is projected to grow at a CAGR of 9.07% through 2032, ultimately reaching USD 26.76 billion. This growth trend demonstrates robust global demand, as device-based therapies become increasingly central to heart failure management. Both mature and developing regions contribute to rising adoption rates, reflecting a broad shift towards integrated, technology-driven care solutions across diverse healthcare infrastructures.

Scope & Segmentation of the Heart Failure Device Market

This report delivers a comprehensive analysis of trends and opportunities in the congestive heart failure treatment device market, offering actionable insights across the value chain. The assessment considers diverse commercial strategies and regional market drivers, with emphasis on several key segments:

Device Types: Cardiac Resynchronization Therapy Devices, Implantable Cardioverter Defibrillators, and Ventricular Assist Devices, including biventricular, left, and right configurations, each directly impacting therapeutic practice and capital procurement planning.
Therapeutic Modalities: Electrical Stimulation modalities such as asynchronous and synchronous pacemakers, and Mechanical Circulatory Support options, all of which influence adoption patterns and clinical workflow integration.
End Users: Ambulatory Surgical Centers, Hospitals, and Specialty Clinics, each exhibiting distinct device needs, procurement cycles, and service requirements driven by their operational models.
Distribution Channels: Direct Sales, Distributors, and Online Sales, representing varying routes to market and impacting partnership structures as well as regional supply strategies.
Geographies: Americas, Europe, Middle East & Africa, and Asia-Pacific, where varied regulatory environments, reimbursement strategies, and healthcare delivery standards dictate market velocity and shape local opportunities.

By understanding the scope and segmentation, senior leaders can align investment strategies with specific segment needs, optimize procurement frameworks, and address regional dynamics more effectively.

Key Takeaways for Senior Decision-Makers

Advancing device modalities support earlier heart failure interventions and enable improved real-time patient monitoring in both acute and chronic settings.
Integration of digital and remote-management technologies is facilitating scalable care and strengthening longitudinal patient outcomes.
Manufacturers must address heightened expectations for device safety, durability, and seamless clinical data integration as part of evolving procurement standards.
Effective procurement planning now incorporates interoperability, post-deployment service levels, and lifecycle total cost to inform capital expenditure decisions.
Local market entry strategies require navigation of regional regulatory barriers, reimbursement structures, and evolving sourcing requirements to achieve resilience and optimize cost structures.
Combining device performance with tailored clinical support and adaptive commercial models is critical to creating differentiated value in the current competitive environment.

Tariff Impact on Supply Chain Structure and Commercial Models

Cumulative tariff actions in 2025 have substantially altered supplier dynamics, input pricing, and procurement flexibility. With critical components like precision motors and specialized sensors relying on intricate global flows, manufacturers are increasingly vulnerable to trade disruptions. Rising import costs are prompting a move toward localizing production, diversifying supply chains, and refining component sourcing strategies to buffer against market shocks. In response, health systems and group purchasing organizations are recalibrating procurement cycles as suppliers revisit production locales and adjust pricing structures. Strengthened customs compliance and enhanced regulatory coordination have taken precedence, requiring agile, cross-functional collaboration to maintain supply continuity and limit business risk.

Methodology & Data Sources

This analysis uses a robust mixed-methods framework. Insights were derived from structured interviews with clinicians, procurement leaders, and service engineers, backed by regulatory and guidelines review. Supplementary secondary research spanned patent reviews, regulatory filings, clinical approvals, and supply chain mapping. Scenario modeling evaluated policy impacts on sourcing practices, supporting actionable intelligence for manufacturers and providers.

Why This Report Matters

Delivers a strategic overview of the shifting clinical, technological, and policy landscape shaping the congestive heart failure device market, with a focus on actionable intelligence for senior leaders.
Enables forward-looking planning for procurement and regulatory compliance, ensuring organizations can form effective partnerships within targeted regional ecosystems.
Equips stakeholders with practical strategies to counter supply chain uncertainty and protect operating margins as global policies evolve.

Conclusion: Pathways to Sustainable Leadership

Sustained leadership in the congestive heart failure treatment device market will depend on the capacity to integrate technology advancement with adaptive care models and resilient supply chains. Strategic flexibility and robust execution will be essential to enduring market success.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025

8. Congestive Heart Failure Treatment Device Market, by Device Type

8.1. Cardiac Resynchronization Therapy Device
8.2. Implantable Cardioverter Defibrillator
8.3. Ventricular Assist Device
8.3.1. Biventricular Assist Device
8.3.2. Left Ventricular Assist Device
8.3.3. Right Ventricular Assist Device

9. Congestive Heart Failure Treatment Device Market, by Therapeutic Modality

9.1. Electrical Stimulation
9.1.1. Asynchronous Pacemakers
9.1.2. Synchronous Pacemakers
9.2. Mechanical Circulatory Support

10. Congestive Heart Failure Treatment Device Market, by End User

10.1. Ambulatory Surgical Centers
10.2. Hospitals
10.3. Specialty Clinics

11. Congestive Heart Failure Treatment Device Market, by Distribution Channel

11.1. Direct Sales
11.2. Distributors
11.3. Online Sales

12. Congestive Heart Failure Treatment Device Market, by Region

12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific

13. Congestive Heart Failure Treatment Device Market, by Group

13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO

14. Congestive Heart Failure Treatment Device Market, by Country

14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea

15. United States Congestive Heart Failure Treatment Device Market
16. China Congestive Heart Failure Treatment Device Market

17. Competitive Landscape

17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Abbott Laboratories
17.6. Abiomed, Inc.
17.7. Biotronik SE & Co. KG
17.8. Boston Scientific Corporation
17.9. Getinge AB
17.10. Jarvik Heart Inc.
17.11. LivaNova PLC
17.12. Medtronic plc
17.13. MicroPort Scientific Corporation
17.14. Otsuka Pharmaceutical Co., Ltd.
17.15. SynCardia Systems LLC

List of Figures

FIGURE 1. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY DEVICE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY DEVICE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY DEVICE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY BIVENTRICULAR ASSIST DEVICE, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY BIVENTRICULAR ASSIST DEVICE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY BIVENTRICULAR ASSIST DEVICE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICE, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY RIGHT VENTRICULAR ASSIST DEVICE, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY RIGHT VENTRICULAR ASSIST DEVICE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY RIGHT VENTRICULAR ASSIST DEVICE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ASYNCHRONOUS PACEMAKERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ASYNCHRONOUS PACEMAKERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ASYNCHRONOUS PACEMAKERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY SYNCHRONOUS PACEMAKERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY SYNCHRONOUS PACEMAKERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY SYNCHRONOUS PACEMAKERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ONLINE SALES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. AMERICAS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 58. AMERICAS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 59. AMERICAS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
TABLE 60. AMERICAS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
TABLE 61. AMERICAS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2018-2032 (USD MILLION)
TABLE 62. AMERICAS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 63. AMERICAS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 64. NORTH AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. NORTH AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 66. NORTH AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
TABLE 67. NORTH AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
TABLE 68. NORTH AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2018-2032 (USD MILLION)
TABLE 69. NORTH AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 70. NORTH AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 71. LATIN AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. LATIN AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 73. LATIN AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
TABLE 74. LATIN AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
TABLE 75. LATIN AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2018-2032 (USD MILLION)
TABLE 76. LATIN AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 77. LATIN AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2018-2032 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 85. EUROPE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. EUROPE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 87. EUROPE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
TABLE 88. EUROPE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
TABLE 89. EUROPE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2018-2032 (USD MILLION)
TABLE 90. EUROPE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 91. EUROPE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 92. MIDDLE EAST CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. MIDDLE EAST CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 94. MIDDLE EAST CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
TABLE 95. MIDDLE EAST CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
TABLE 96. MIDDLE EAST CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2018-2032 (USD MILLION)
TABLE 97. MIDDLE EAST CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 98. MIDDLE EAST CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 99. AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 101. AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
TABLE 102. AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
TABLE 103. AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2018-2032 (USD MILLION)
TABLE 104. AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 105. AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 106. ASIA-PACIFIC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 107. ASIA-PACIFIC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 108. ASIA-PACIFIC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
TABLE 109. ASIA-PACIFIC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
TABLE 110. ASIA-PACIFIC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2018-2032 (USD MILLION)
TABLE 111. ASIA-PACIFIC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 112. ASIA-PACIFIC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 114. ASEAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 115. ASEAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 116. ASEAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
TABLE 117. ASEAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
TABLE 118. ASEAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2018-2032 (USD MILLION)
TABLE 119. ASEAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 120. ASEAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 121. GCC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 122. GCC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 123. GCC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
TABLE 124. GCC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
TABLE 125. GCC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2018-2032 (USD MILLION)
TABLE 126. GCC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 127. GCC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 128. EUROPEAN UNION CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 129. EUROPEAN UNION CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 130. EUROPEAN UNION CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
TABLE 131. EUROPEAN UNION CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
TABLE 132. EUROPEAN UNION CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2018-2032 (USD MILLION)
TABLE 133. EUROPEAN UNION CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 134. EUROPEAN UNION CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 135. BRICS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 136. BRICS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 137. BRICS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
TABLE 138. BRICS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
TABLE 139. BRICS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2018-2032 (USD MILLION)
TABLE 140. BRICS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 141. BRICS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 142. G7 CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 143. G7 CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 144. G7 CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
TABLE 145. G7 CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
TABLE 146. G7 CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2018-2032 (USD MILLION)
TABLE 147. G7 CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 148. G7 CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 149. NATO CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 150. NATO CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 151. NATO CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
TABLE 152. NATO CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
TABLE 153. NATO CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2018-2032 (USD MILLION)
TABLE 154. NATO CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 155. NATO CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 156. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 157. UNITED STATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 158. UNITED STATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 159. UNITED STATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
TABLE 160. UNITED STATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
TABLE 161. UNITED STATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2018-2032 (USD MILLION)
TABLE 162. UNITED STATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 163. UNITED STATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 164. CHINA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 165. CHINA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 166. CHINA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
TABLE 167. CHINA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
TABLE 168. CHINA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2018-2032 (USD MILLION)
TABLE 169. CHINA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 170. CHINA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Congestive Heart Failure Treatment Device market report include:

Abbott Laboratories
Abiomed, Inc.
Biotronik SE & Co. KG
Boston Scientific Corporation
Getinge AB
Jarvik Heart Inc.
LivaNova PLC
Medtronic plc
MicroPort Scientific Corporation
Otsuka Pharmaceutical Co., Ltd.
SynCardia Systems LLC

Table Information

Report Attribute	Details
No. of Pages	184
Published	January 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 15.64 Billion
Forecasted Market Value ( USD ) by 2032	$ 26.76 Billion
Compound Annual Growth Rate	9.0%
Regions Covered	Global
No. of Companies Mentioned	12

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3447EUR$3,939USD£2,988GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3719EUR$4,249USD£3,223GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5040EUR$5,759USD£4,368GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6099EUR$6,969USD£5,286GBP

Congestive Heart Failure Treatment Device Market - Global Forecast 2026-2032

Market Snapshot: Congestive Heart Failure Treatment Device Market

Scope & Segmentation of the Heart Failure Device Market

Key Takeaways for Senior Decision-Makers

Tariff Impact on Supply Chain Structure and Commercial Models

Methodology & Data Sources

Why This Report Matters

Conclusion: Pathways to Sustainable Leadership

Table of Contents

Companies Mentioned

Table Information

Market Snapshot: Congestive Heart Failure Treatment Device Market

Scope & Segmentation of the Heart Failure Device Market

Key Takeaways for Senior Decision-Makers

Tariff Impact on Supply Chain Structure and Commercial Models

Methodology & Data Sources

Why This Report Matters

Conclusion: Pathways to Sustainable Leadership

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Congestive Heart Failure Treatment Devices Market Report 2025

Congestive Heart Failure Treatment Device Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

Congestive Heart Failure Treatment Devices: Market Share, and Growth Analysis by Product Type (Implantable Devices, External Devices), Application, End User, Technology

Congestive Heart Failure (CHF) Treatment Devices - Global Strategic Business Report

Cardiac Rhythm Management Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

About the Congestive Heart Failure Device Market